(44) performed 177Lu-FAP-2286 for peptide-targeted radionuclide therapy (PTRT) in 11 patients with advanced adenocarcinomas of pancreas, breast, rectum, and ovary after prior confirmation of uptake on 68Ga-FAP-2286 or 68Ga-FAPI-04 PET/CT. The gene discussed is FAP; the disease is adenocarcinoma.